NCT02342561

Brief Summary

This study evaluates the effect of Iodine-impregnated self-adhesive plastic drapes (IIAD) on the quantity of skin bacteria, which is a known factor in the development of surgical site infections in orthopedic surgery. 16 patients scheduled for total knee replacement surgery (TKA) are recruited for participation in an intervention performed at the orthopedic ward of Odense University Hospital, Denmark. Right or left patient knee is randomized to receive draping with IIAD, while the other knee is not draped. Local standard preoperative procedure for knee surgery is then simulated. After 75 minutes both knee are sampled for bacterial quantity using the cup scrub method and samples are aerobically incubated. The bacterial growth of the IIAD and no-drape group are then compared using nonparametric statistics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 14, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 21, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
4 months until next milestone

Results Posted

Study results publicly available

December 11, 2015

Completed
Last Updated

December 11, 2015

Status Verified

November 1, 2015

Enrollment Period

10 months

First QC Date

January 14, 2015

Results QC Date

September 1, 2015

Last Update Submit

November 8, 2015

Conditions

Keywords

InfectionDrapeIobanArthroplastyKneeCylinder SamplingBacteria

Outcome Measures

Primary Outcomes (1)

  • Bacterial Quantity

    The bacterial quantity of the skin in sampled using the cylinder sampling method and incubated for 36-48 hours. Manually counted growth is reported as log10 Colony forming units (CFU)/cm\^2

    Measured after skin disinfection and 75 minutes after drape application

Secondary Outcomes (1)

  • Description of Bacterial Skin Flora

    Samples collected 75 minutes after drape application are analysed

Study Arms (2)

Intervention knees (Drape side)

EXPERIMENTAL

One knee of the patient is randomly selected to be drape with an Ioban 2 incision drape.

Device: Ioban 2 incision drape, 3M

Control knees (no-drape side)

NO INTERVENTION

The knee that is not drape is left uncovered during the intervention.

Interventions

The anterior knee of the patient is covered with an Ioban 2 drape for 75 minutes. The drape is applied and removed in accordance with product instructions.

Also known as: Ioban 2 antimicrobial incision drape, 3M
Intervention knees (Drape side)

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is scheduled for primary knee replacement surgery (TKA).

You may not qualify if:

  • Patient age under 50 year
  • Patient is allergic to iodine
  • Patient has received antibiotic treatment within 4 weeks of intervention.
  • Patient suffers from a chronic skin disease with lesions in the knee area
  • Patient has lesions of the skin due to trauma suffered within 1 week of intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ortopeadic research Unit, Odense University Hospital

Odense, 5000, Denmark

Location

Related Publications (38)

  • Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999 Apr;20(4):250-78; quiz 279-80. doi: 10.1086/501620. No abstract available.

    PMID: 10219875BACKGROUND
  • Anderson DJ, Kaye KS, Classen D, Arias KM, Podgorny K, Burstin H, Calfee DP, Coffin SE, Dubberke ER, Fraser V, Gerding DN, Griffin FA, Gross P, Klompas M, Lo E, Marschall J, Mermel LA, Nicolle L, Pegues DA, Perl TM, Saint S, Salgado CD, Weinstein RA, Wise R, Yokoe DS. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008 Oct;29 Suppl 1:S51-61. doi: 10.1086/591064. No abstract available.

    PMID: 18840089BACKGROUND
  • Webster J, Alghamdi AA. Use of plastic adhesive drapes during surgery for preventing surgical site infection. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006353. doi: 10.1002/14651858.CD006353.pub2.

    PMID: 17943905BACKGROUND
  • Johnston DH, Fairclough JA, Brown EM, Morris R. Rate of bacterial recolonization of the skin after preparation: four methods compared. Br J Surg. 1987 Jan;74(1):64. doi: 10.1002/bjs.1800740121. No abstract available.

    PMID: 3828740BACKGROUND
  • Lewis DA, Leaper DJ, Speller DC. Prevention of bacterial colonization of wounds at operation: comparison of iodine-impregnated ('Ioban') drapes with conventional methods. J Hosp Infect. 1984 Dec;5(4):431-7. doi: 10.1016/0195-6701(84)90013-6.

    PMID: 6085099BACKGROUND
  • Brush M. Surgical preparation and site acces: Testing´s stepchild. In: Paulson DS, editor. Handbook of topical antimicrobials: Industrial applications in consumer products and pharmaceutical. New York: Marcel Dekker Inc; 2003. p. 197-220.

    BACKGROUND
  • Selwyn S. Evaluating skin disinfectants in vivo by excision biopsy and other methods. J Hosp Infect. 1985 Mar;6 Suppl A:37-43. doi: 10.1016/s0195-6701(85)80044-x. No abstract available.

    PMID: 2860174BACKGROUND
  • So BK, Chu CC, Ho PL, Chow KH, Leung JN, Lee IY, Lin CK, Lee CK. Evaluation of two chlorhexidine-alcohol-based skin disinfectants in blood donation setting. Vox Sang. 2014 May;106(4):316-21. doi: 10.1111/vox.12107.

    PMID: 24877234BACKGROUND
  • Fleischmann W, Meyer H, von Baer A. Bacterial recolonization of the skin under a polyurethane drape in hip surgery. J Hosp Infect. 1996 Oct;34(2):107-16. doi: 10.1016/s0195-6701(96)90135-8.

    PMID: 8910752BACKGROUND
  • Wilson SE. Microbial sealing: a new approach to reducing contamination. J Hosp Infect. 2008 Nov;70 Suppl 2:11-4. doi: 10.1016/S0195-6701(08)60018-3.

    PMID: 19022116BACKGROUND
  • 3M HC. 3M incise drapes 2014 [cited 2014 Oktober 29th]. Available from: http://solutions.3m.com/wps/portal/3M/en_US/IPD-NA/3M-Infection-Prevention/products/catalog/~/All-3M-Products/Industry-and-Professionals/Medical-Supplies-Software/Infection-Prevention-Products/Incise-Drapes?N=5716450&rt=c3.

    BACKGROUND
  • Chiu KY, Lau SK, Fung B, Ng KH, Chow SP. Plastic adhesive drapes and wound infection after hip fracture surgery. Aust N Z J Surg. 1993 Oct;63(10):798-801. doi: 10.1111/j.1445-2197.1993.tb00343.x.

    PMID: 8274123BACKGROUND
  • Falk-Brynhildsen K, Friberg O, Soderquist B, Nilsson UG. Bacterial colonization of the skin following aseptic preoperative preparation and impact of the use of plastic adhesive drapes. Biol Res Nurs. 2013 Apr;15(2):242-8. doi: 10.1177/1099800411430381. Epub 2012 Jan 24.

    PMID: 22278031BACKGROUND
  • Marples RR, Kligman AM. Growth of bacteria under adhesive tapes. Arch Dermatol. 1969 Jan;99(1):107-10. No abstract available.

    PMID: 5761791BACKGROUND
  • Dewan PA, Van Rij AM, Robinson RG, Skeggs GB, Fergus M. The use of an iodophor-impregnated plastic incise drape in abdominal surgery--a controlled clinical trial. Aust N Z J Surg. 1987 Nov;57(11):859-63. doi: 10.1111/j.1445-2197.1987.tb01281.x.

    PMID: 3326567BACKGROUND
  • Kramer A, Assadian O, Lademann J. Prevention of postoperative wound infections by covering the surgical field with iodine-impregnated incision drape (Ioban 2). GMS Krankenhhyg Interdiszip. 2010 Sep 21;5(2):Doc08. doi: 10.3205/dgkh000151.

    PMID: 20941338BACKGROUND
  • Nichols RL. Surgical infections: prevention and treatment--1965 to 1995. Am J Surg. 1996 Jul;172(1):68-74. doi: 10.1016/S0002-9610(96)00049-9.

    PMID: 8686806BACKGROUND
  • Danish Orthopeadic Society. Reference program, Primary knee arthroplastic surgery. 2007.

    BACKGROUND
  • Falk-Brynhildsen K, Soderquist B, Friberg O, Nilsson UG. Bacterial recolonization of the skin and wound contamination during cardiac surgery: a randomized controlled trial of the use of plastic adhesive drape compared with bare skin. J Hosp Infect. 2013 Jun;84(2):151-8. doi: 10.1016/j.jhin.2013.02.011. Epub 2013 Apr 25.

    PMID: 23623487BACKGROUND
  • Fairclough JA, Johnson D, Mackie I. The prevention of wound contamination by skin organisms by the pre-operative application of an iodophor impregnated plastic adhesive drape. J Int Med Res. 1986;14(2):105-9. doi: 10.1177/030006058601400210.

    PMID: 3699240BACKGROUND
  • Bashir MH, Olson LK, Walters SA. Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin. Am J Infect Control. 2012 May;40(4):344-8. doi: 10.1016/j.ajic.2011.03.030. Epub 2011 Jul 7.

    PMID: 21737178BACKGROUND
  • Aly R, Bayles C, Maibach H. Restriction of bacterial growth under commercial catheter dressings. Am J Infect Control. 1988 Jun;16(3):95-100. doi: 10.1016/0196-6553(88)90045-4.

    PMID: 3408019BACKGROUND
  • Callahan JL, Wesorick B. Bacterial growth under a transparent dressing. Am J Infect Control. 1987 Dec;15(6):231-7. doi: 10.1016/0196-6553(87)90116-7.

    PMID: 3439642BACKGROUND
  • Waxman BP, Easmon CS, Dudley HA. Skin bacteria and Op Site chest dressings. Clin Nutr. 1985 Feb;4(1):29-34. doi: 10.1016/0261-5614(85)90034-2.

    PMID: 16831700BACKGROUND
  • Faoagali J, Fong J, George N, Mahoney P, O'Rourke V. Comparison of the immediate, residual, and cumulative antibacterial effects of Novaderm R,* Novascrub R,* Betadine Surgical Scrub, Hibiclens, and liquid soap. Am J Infect Control. 1995 Dec;23(6):337-43. doi: 10.1016/0196-6553(95)90263-5.

    PMID: 8821108BACKGROUND
  • Wade JJ, Casewell MW. The evaluation of residual antimicrobial activity on hands and its clinical relevance. J Hosp Infect. 1991 Jun;18 Suppl B:23-8. doi: 10.1016/0195-6701(91)90259-b.

    PMID: 1679443BACKGROUND
  • Sogawa Y, Kobayashi H. Comparison of residual antimicrobial activity of chlorhexidine-containing antiseptics: An express report. Journal of Healthcare-associated Infection. 2010;2:32-6.

    BACKGROUND
  • Ritter MA, Campbell ED. Retrospective evaluation of an iodophor-incorporated antimicrobial plastic adhesive wound drape. Clin Orthop Relat Res. 1988 Mar;(228):307-8.

    PMID: 3342583BACKGROUND
  • Billhimer WL, Berge CA, Englehart JS, Rains GY, Keswick BH. A modified cup scrub method for assessing the antibacterial substantivity of personal cleansing products. J Cosmet Sci. 2001 Nov-Dec;52(6):369-75.

    PMID: 11773954BACKGROUND
  • Williamson P, Kligman AM. A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol. 1965 Dec;45(6):498-503. doi: 10.1038/jid.1965.164. No abstract available.

    PMID: 5321315BACKGROUND
  • Hambraeus A, Hoborn J, Whyte W. Skin sampling-validation of a pad method and comparison with commonly used methods. J Hosp Infect. 1990 Jul;16(1):19-27. doi: 10.1016/0195-6701(90)90045-p.

    PMID: 1974903BACKGROUND
  • Beausoleil CM. A guide for validation of neutralizer systems. In: Paulson DS, editor. Handbook of topical antimicrobials: Industrial applications in consumer products and pharmaceutical. New York: Marcel Dekker Inc; 2003. p. 365-76.

    BACKGROUND
  • Kampf G. What is left to justify the use of chlorhexidine in hand hygiene? J Hosp Infect. 2008 Oct;70 Suppl 1:27-34. doi: 10.1016/S0195-6701(08)60008-0.

    PMID: 18994679BACKGROUND
  • Shimizu M, Okuzumi K, Yoneyama A, Kunisada T, Araake M, Ogawa H, Kimura S. In vitro antiseptic susceptibility of clinical isolates from nosocomial infections. Dermatology. 2002;204 Suppl 1:21-7. doi: 10.1159/000057720.

    PMID: 12011516BACKGROUND
  • Zamany A, Spangberg LS. An effective method of inactivating chlorhexidine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 May;93(5):617-20. doi: 10.1067/moe.2002.122346.

    PMID: 12075214BACKGROUND
  • Bloom E, Aly R, Maibach HI. Quantitation of skin bacteria: lethality of the wash solution used to remove bacteria. Acta Derm Venereol. 1979;59(5):460-3.

    PMID: 93373BACKGROUND
  • Reichel M, Heisig P, Kampf G. Pitfalls in efficacy testing--how important is the validation of neutralization of chlorhexidine digluconate? Ann Clin Microbiol Antimicrob. 2008 Dec 2;7:20. doi: 10.1186/1476-0711-7-20.

    PMID: 19046465BACKGROUND
  • Cecilio. RL PF, Palileo. E,. Microbiological efficacy of Chlorhexidine: An In Vitro Study on 400 Bacterial Isolates from Four Metro Manila Hospitals. Phil J Microbial Dis. 1983;12:7-13.

    BACKGROUND

MeSH Terms

Conditions

Infections

Results Point of Contact

Title
Nikolaj Milandt, Undergraduate researcher
Organization
The Orthopaedic Research Unit, Department of Orthopaedic Surgery and Trauma, Odense University Hospital, Denmark

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
stud. cand. med, BA Clinical Biomechanics

Study Record Dates

First Submitted

January 14, 2015

First Posted

January 21, 2015

Study Start

September 1, 2014

Primary Completion

July 1, 2015

Study Completion

August 1, 2015

Last Updated

December 11, 2015

Results First Posted

December 11, 2015

Record last verified: 2015-11

Locations